Sator格羅夫控股

2023年5月24日

24.05.2023 / 29 CET(中央東部東京)/ c發行人單獨負責這個聲明的內容。MEDIQON集團:2022年年度報告——強大的經營業績和持續成功收購——重命名和新董事提議在AGM著手下一章上周的增長,該公司公布2022年年度報告。與26日運營公司在年底,集團實現了67.1歐元的收入在2022年和2022年EBITDA 16.8歐元,增長64%和38%,分別比上年。雖然結果主要是由公司的成功的收購活動的平台組,同比2022年EBITDA增長也在+ 6.6%強。我們預計貪婪和有機增長在2023年繼續。五年前,該公司開始了新的一頁,當最初的“醫療哥倫布”集團的業務是出售,所得用於啟動當前控股公司結構。隨著時間的推移,我們進化非常,吸引優秀人才,企業主和一組質量世界一流股東加入我們的努力。這導致了我們的願景和野心的快速擴張。展望未來,公司董事會提出重命名章節集團。我們選擇這個名字來表達我們的信念,我們將開始一些新的和成功在未來公司的章。 To help us shape this next phase of our development, the company is seeking to add a talented and experienced investor and company builder to our supervisory board. Given his breadth of experience and talent, the company has asked Paul Buser to consider a nomination to join our supervisory board as a non-executive director. Paul is the co-founder and co-CEO of Sator Grove Holdings, one of our long-time shareholders. Paul has multiple decades of experience including as an investor, board member and executive. The company is pleased to propose his election at the upcoming AGM. “It’s an honor to be considered for the Supervisory Board at MEDIQON Group AG,” said Paul. “We have known and admired this team since its transformation from Medical Columbus and today serve as the company’s largest shareholder. The new ‘CHAPTERS GROUP’ is poised to accelerate its ambitions and seek to become the premier home for outstanding businesses and entrepreneurial talent across Europe. The structure that the management team has put in place should provide the opportunity to achieve this bold vision. I'm confident that top-tier talent will continue to be attracted to the CHAPTERS ecosystem – and the shareholder base consisting of long-term oriented world-class operators and investors will provide additional support to help us imagine and achieve the art of what’s possible. We stand ready to assist in any way to advance the mission of the company.” If approved, Paul would take over from Lars Ahns who offered his board seat to allow Paul to join. Lars has been a board member for nine years. During his leadership, the company transformed to its current form and his governance ensured an orderly and thoughtful reorganization of the group. Mathias Saggau, Chairman of the Supervisory Board, added, “I want to thank Lars for his great service over the last years. He has been a great supporter and advisor to our management team and we will miss his contributions. We are excited that Paul agreed to stand for election at the next AGM. The guidance and network that Paul and his team at Sator Grove have provided over the past years as shareholders have had a tremendous positive impact. We are looking forward to working together closely.” “It’s bittersweet leaving the business at this juncture given the tremendous progress we’ve made and the fulfilling nature of working alongside the team,” said Lars Ahns. “I will remain closely connected to the company as a shareholder and wish Paul and the company all the best in the coming years ahead.” Our shareholders will have the chance to vote on both the proposed name change and Paul Buser’s appointment at the upcoming AGM on June, 29th, 2023 This year’s AGM will take place in Hamburg and we also propose to move our legal seat to Hamburg as that’s where our management head office has been located since 2020. The invite to the event can be downloaded via the website of the company: Hauptversammlung - MEDIQON group AG (mediqon-group.de) After the AGM, we are holding an Investor Event in English. Details on the event will be published on our website shortly. Please sign up via ir@mediqon-group.de. 24.05.2023 CET/CEST Dissemination of a Corporate News, transmitted by EQS News - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement. The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Archive at www.eqs-news.com